Also trades as: 0LTI.L (LSE) · $vol 0M

$342.37

+1.38 (+0.40%)

Weekly Expected Move ±9.3%

$268 $299 $329 $360 $390

NYSE · Healthcare · Medical - Diagnostics & Research · Alpha Radar Buy · Power 62 · $22.3B mcap · 65M float · 1.68% daily turnover · Short 70% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE

35.8 / 100

NoneWeakNarrowWide

Primary source: Efficient Scale · ROIC: 16.3% · 5Y Avg: 35.2%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale ★

100

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. WAT has No discernible competitive edge (35.8/100). The business operates without significant structural advantages. The primary source of advantage is Efficient Scale. ROIC of 16.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$350

Low

$384

Avg Target

$425

High

Based on 4 analysts since May 5, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 11Hold: 20Sell: 3Strong Sell: 0

Rating Summary

ConsensusHold

Avg Target$384.25

Analysts4

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-05-07	Deutsche Bank	—	$315	$350	+35	-0.4%	$351.33
2026-05-07	Barclays	—	$400	$425	+25	+21.6%	$349.53
2026-05-06	UBS	—	$370	$375	+5	+6.3%	$352.64
2026-05-06	Robert W. Baird	—	$363	$387	+24	+12.9%	$342.75
2026-02-22	Morgan Stanley	—	$423	$350	-73	+5.0%	$333.33
2026-02-10	UBS	—	Initiated	$370	—	+12.9%	$327.59
2026-02-10	Robert W. Baird	—	$374	$363	-11	+11.3%	$326.16
2026-02-10	Barclays	—	$300	$400	+100	+21.9%	$328.14
2026-01-06	Guggenheim	Subbu Nambi	Initiated	$440	—	+11.4%	$394.97
2025-12-15	Wells Fargo	Brandon Couillard	$380	$415	+35	+7.7%	$385.33
2025-12-10	Wolfe Research	Doug Schenkel	Initiated	$480	—	+24.3%	$386.16
2025-12-01	Morgan Stanley	—	Initiated	$423	—	+6.3%	$397.79
2025-10-08	Redburn Partners	Natalya Davies	Initiated	$390	—	+22.5%	$318.35
2025-08-05	Deutsche Bank	—	Initiated	$315	—	+12.0%	$281.19
2025-08-04	Jefferies	—	$415	$385	-30	+34.8%	$285.59
2025-07-11	Scotiabank	Sung Ji Nam	Initiated	$465	—	+31.8%	$352.70
2025-05-07	Robert W. Baird	Catherine Ramsey Schulte	$407	$374	-33	+10.3%	$339.02
2025-04-16	Bernstein	Eve Burstein	Initiated	$400	—	+24.6%	$321.10
2025-03-26	Robert W. Baird	Catherine Ramsey Schulte	Initiated	$407	—	+10.7%	$367.79
2024-10-17	CFRA	Jonathan Sakraida	Initiated	$389	—	+12.0%	$347.31
2024-10-08	Jefferies	Tycho Peterson	$320	$415	+95	+18.6%	$349.92
2024-08-27	Wells Fargo	Brandon Couillard	$315	$380	+65	+12.8%	$336.77
2024-08-01	Barclays	Luke Sergott	Initiated	$300	—	-14.9%	$352.53
2024-07-02	Evercore ISI	Vijay Kumar	$320	$300	-20	+6.1%	$282.70
2024-06-03	Jefferies	Tycho Peterson	Initiated	$320	—	+3.6%	$308.90
2024-05-07	Evercore ISI	Vijay Kumar	$365	$320	-45	-1.9%	$326.06
2022-07-12	Evercore ISI	Vijay Kumar	Initiated	$365	—	+6.9%	$341.41
2022-04-25	Wells Fargo	—	Initiated	$315	—	+6.3%	$296.44

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

May 22, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. WAT receives an overall rating of B. Strongest factors: ROA (4/5). Areas of concern: D/E (2/5), P/E (1/5).

Rating Change History

Date	From	To
2026-04-01	B+	B
2026-03-31	B	B+
2026-03-02	B+	B
2026-02-17	B	B+
2026-01-30	B+	B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 43 Grade C

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

100

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. WAT scores highest in Safety (100/100) and lowest in Value (20/100). A grade of C represents mixed fundamentals — strengths in some areas offset by weaknesses.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

7.55

Safe Zone

Piotroski F-Score

4/9

✓ ✓ ✗ ✗ ✓ ✗ ✗ ✗ ✓

Beneish M-Score

-1.85

Unlikely Manipulator

Ohlson O-Score

-8.38

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

AA-

Score: 82.3/100

Trend: Deteriorating

Earnings Quality

75/100

OCF/NI: 0.87x

Accruals: 1.2%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. WAT scores 7.55, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. WAT scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. WAT's score of -1.85 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. WAT's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. WAT receives an estimated rating of AA- (score: 82.3/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). WAT's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

62.60x

PEG

-2.17x

P/S

5.92x

P/B

1.84x

P/FCF

94.66x

P/OCF

64.08x

EV/EBITDA

27.92x

EV/Revenue

6.84x

EV/EBIT

41.93x

EV/FCF

97.76x

Earnings Yield

1.80%

FCF Yield

1.06%

Shareholder Yield

0.05%

Graham Number

$61.95

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 62.6x earnings, WAT is priced for high growth expectations. Graham's intrinsic value formula yields $61.95 per share, 453% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.857

NI / EBT

Interest Burden

0.851

EBT / EBIT

EBIT Margin

0.163

EBIT / Rev

Asset Turnover

0.782

Rev / Assets

Equity Multiplier

2.196

Assets / Equity

ROE

20.5%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. WAT's ROE of 20.5% is driven by Asset Turnover (0.782), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

$46.49

Price/Value

6.54x

Margin of Safety

-554.43%

Premium

554.43%

Assessment

Overvalued

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with WAT's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. WAT trades at a 554% premium to its adjusted intrinsic value of $46.49, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 62.6x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$342.46

Median 1Y

$339.55

5th Pctile

$196.04

95th Pctile

$587.95

Ann. Volatility

33.2%

Analyst Target

$384.25

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Udit Batra, Ph.D., President & CEO	$1,150,000	$7,430,247	$13,973,044
Amol Chaubal, SVP & CFO	$650,000	$1,732,598	$3,844,298
Jianqing Y. Bennett, SVP, TA & Clinical Division	$633,000	$1,280,262	$2,966,345
Robert Carpio III, SVP, Waters Division	$600,000	$1,129,966	$2,819,704

CEO Pay Ratio

23:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $13,973,044

Avg Employee Cost (SGA/emp): $616,892

Employees: 1,200

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

1,200

-84.2% YoY

Revenue / Employee

$2,637,738

Rev: $3,165,286,000

Profit / Employee

$535,524

NI: $642,629,000

SGA / Employee

$616,892

Avg labor cost proxy

R&D / Employee

$162,650

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
ROE	83.3%	87.6%	2.3%	2.3%	2.3%	2.3%	1.6%	1.6%	1.5%	1.5%	77.6%	72.9%	72.0%	75.3%	42.8%	44.1%	44.4%	43.6%	29.3%	20.5%	20.47%
ROA	24.5%	25.8%	23.3%	23.7%	23.7%	23.5%	22.2%	21.6%	21.2%	20.5%	16.2%	15.3%	15.1%	15.7%	13.9%	14.3%	14.4%	14.1%	13.3%	9.3%	9.32%
ROIC	53.9%	56.8%	50.5%	52.0%	52.3%	51.9%	43.7%	42.6%	42.4%	42.0%	22.3%	21.4%	21.2%	21.7%	21.8%	22.1%	22.0%	21.7%	21.2%	16.3%	16.33%
ROCE	40.5%	42.1%	35.3%	35.8%	35.6%	35.6%	35.5%	34.8%	34.8%	34.3%	21.8%	20.7%	20.5%	21.3%	22.4%	22.9%	22.9%	22.4%	16.1%	12.1%	12.11%
Gross Margin	58.9%	58.9%	58.0%	58.6%	57.0%	56.7%	59.4%	58.5%	59.3%	59.1%	61.2%	58.9%	59.3%	59.3%	60.1%	58.2%	58.3%	59.0%	59.8%	47.0%	46.96%
Operating Margin	28.8%	29.1%	31.3%	28.3%	27.9%	27.1%	33.3%	25.4%	27.0%	25.2%	32.2%	21.0%	26.7%	28.5%	33.5%	22.9%	24.4%	24.0%	33.3%	-3.7%	-3.71%
Net Margin	24.5%	24.5%	25.9%	23.1%	23.1%	22.0%	26.4%	20.6%	20.3%	18.9%	26.4%	16.0%	20.1%	21.8%	26.5%	18.3%	19.1%	18.6%	24.2%	-5.7%	-5.68%
EBITDA Margin	35.6%	34.4%	35.5%	33.4%	33.3%	32.2%	37.4%	30.8%	32.7%	32.5%	38.6%	29.7%	33.9%	35.5%	39.5%	31.2%	31.6%	31.2%	34.9%	8.4%	8.37%
FCF Margin	24.0%	22.9%	20.8%	19.7%	16.7%	16.0%	14.7%	14.6%	12.9%	13.0%	15.0%	17.7%	19.5%	21.3%	20.9%	20.8%	20.3%	19.4%	17.1%	7.0%	7.00%
OCF Margin	30.0%	29.1%	26.8%	25.3%	22.1%	21.4%	20.6%	20.6%	19.1%	19.1%	20.4%	23.0%	24.5%	25.9%	25.8%	25.4%	24.5%	23.4%	20.6%	10.3%	10.34%
ROE 3Y Avg	snapshot only																				35.31%
ROE 5Y Avg	snapshot only																				86.83%
ROA 3Y Avg	snapshot only																				12.10%
ROIC 3Y Avg	snapshot only																				20.38%
ROIC Economic	snapshot only																				14.18%
Cash ROA	snapshot only																				7.67%
Cash ROIC	snapshot only																				11.54%
CROIC	snapshot only																				7.81%
NOPAT Margin	snapshot only																				14.64%
Pretax Margin	snapshot only																				13.90%
R&D / Revenue	snapshot only																				6.59%
SGA / Revenue	snapshot only																				26.69%
SBC / Revenue	snapshot only																				1.62%

Valuation

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
P/E Ratio	33.45	31.68	33.03	26.70	29.03	23.24	28.87	26.66	23.32	24.88	30.40	33.90	28.95	34.15	34.69	32.91	31.79	26.81	35.32	55.63	62.598
P/S Ratio	8.27	8.05	8.22	6.56	7.03	5.49	6.88	6.19	5.26	5.42	6.60	7.03	6.00	7.32	7.48	7.25	6.90	5.60	7.17	6.63	5.919
P/B Ratio	95.18	94.83	62.27	51.17	55.46	44.06	40.50	36.41	31.18	32.21	16.97	17.78	14.99	18.48	12.10	11.83	11.50	9.51	8.86	9.76	1.839
P/FCF	34.40	35.16	39.53	33.26	42.08	34.25	46.86	42.41	40.66	41.64	44.16	39.80	30.75	34.29	35.71	34.92	33.94	28.88	42.05	94.66	94.659
P/OCF	27.57	27.63	30.63	25.88	31.81	25.66	33.40	30.08	27.51	28.44	32.39	30.58	24.45	28.27	29.03	28.50	28.20	23.89	34.79	64.08	64.077
EV/EBITDA	24.23	23.29	24.34	19.90	21.58	17.34	21.25	19.60	16.88	17.34	21.55	22.98	19.75	23.12	22.68	21.82	21.19	17.97	22.95	27.92	27.918
EV/Revenue	8.65	8.41	8.59	6.92	7.38	5.84	7.27	6.59	5.65	5.82	7.30	7.74	6.71	8.02	7.94	7.71	7.35	6.04	7.43	6.84	6.845
EV/EBIT	28.05	26.89	28.10	22.96	24.95	20.02	24.38	22.51	19.47	20.36	25.83	28.28	24.56	28.53	27.83	26.71	26.04	22.29	28.73	41.93	41.926
EV/FCF	35.98	36.77	41.31	35.09	44.21	36.44	49.57	45.14	43.71	44.67	48.79	43.78	34.40	37.59	37.93	37.15	36.17	31.16	43.57	97.76	97.764
Earnings Yield	3.0%	3.2%	3.0%	3.7%	3.4%	4.3%	3.5%	3.8%	4.3%	4.0%	3.3%	2.9%	3.5%	2.9%	2.9%	3.0%	3.1%	3.7%	2.8%	1.8%	1.80%
FCF Yield	2.9%	2.8%	2.5%	3.0%	2.4%	2.9%	2.1%	2.4%	2.5%	2.4%	2.3%	2.5%	3.3%	2.9%	2.8%	2.9%	2.9%	3.5%	2.4%	1.1%	1.06%
Price/Tangible Book	snapshot only																				37.693
EV/OCF	snapshot only																				66.178
EV/Gross Profit	snapshot only																				12.442
Acquirers Multiple	snapshot only																				40.083
Shareholder Yield	snapshot only																				0.05%
Graham Number	snapshot only																				$61.95

Leverage & Solvency

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Current Ratio	1.74	1.74	2.39	2.39	2.39	2.39	2.24	2.24	2.24	2.24	2.22	2.22	2.22	2.22	2.11	2.11	2.11	2.11	—	—	—
Quick Ratio	1.36	1.36	1.87	1.87	1.87	1.87	1.66	1.66	1.66	1.66	1.57	1.57	1.57	1.57	1.51	1.51	1.51	1.51	—	—	—
Debt/Equity	6.26	6.26	4.36	4.36	4.36	4.36	3.30	3.30	3.30	3.30	2.12	2.12	2.12	2.12	0.93	0.93	0.93	0.93	0.55	0.55	0.550
Net Debt/Equity	4.35	4.35	2.81	2.81	2.81	2.81	2.34	2.34	2.34	2.34	1.78	1.78	1.78	1.78	0.75	0.75	0.75	0.75	0.32	0.32	0.320
Debt/Assets	0.51	0.51	0.52	0.52	0.52	0.52	0.51	0.51	0.51	0.51	0.53	0.53	0.53	0.53	0.37	0.37	0.37	0.37	0.28	0.28	0.277
Debt/EBITDA	1.52	1.47	1.63	1.61	1.61	1.61	1.64	1.67	1.66	1.65	2.44	2.49	2.50	2.42	1.64	1.62	1.61	1.63	1.37	1.52	1.522
Net Debt/EBITDA	1.06	1.02	1.05	1.04	1.04	1.04	1.16	1.19	1.18	1.18	2.04	2.09	2.09	2.03	1.33	1.31	1.30	1.32	0.80	0.89	0.887
Interest Coverage	18.33	18.98	18.94	19.18	19.31	18.79	18.17	16.64	13.56	10.43	8.45	7.24	7.12	8.06	9.42	10.98	12.46	11.34	12.82	6.72	6.720
Equity Multiplier	12.23	12.23	8.42	8.42	8.42	8.42	6.50	6.50	6.50	6.50	4.02	4.02	4.02	4.02	2.49	2.49	2.49	2.49	1.98	1.98	1.985
Debt Service Coverage	snapshot only																				10.091
Cash to Debt	snapshot only																				0.418
FCF to Debt	snapshot only																				0.188
Defensive Interval	snapshot only																				361.5 days

Efficiency & Turnover

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Asset Turnover	0.99	1.01	0.94	0.97	0.98	0.99	0.93	0.93	0.94	0.94	0.75	0.74	0.73	0.73	0.64	0.65	0.66	0.68	0.66	0.78	0.782
Inventory Turnover	3.58	3.60	3.50	3.60	3.68	3.79	3.08	3.07	3.06	3.02	2.46	2.41	2.39	2.41	2.42	2.45	2.51	2.57	2.48	3.23	3.232
Receivables Turnover	4.60	4.71	4.70	4.84	4.89	4.97	4.45	4.44	4.48	4.49	4.15	4.08	4.04	4.08	4.12	4.16	4.24	4.33	4.05	4.83	4.827
Payables Turnover	18.44	18.58	13.69	14.06	14.38	14.80	13.13	13.12	13.05	12.89	13.43	13.18	13.03	13.15	13.00	13.16	13.52	13.81	26.04	33.95	33.947
DSO	79	77	78	75	75	73	82	82	81	81	88	89	90	90	89	88	86	84	90	76	75.6 days
DIO	102	101	104	101	99	96	119	119	119	121	148	151	153	152	151	149	145	142	147	113	112.9 days
DPO	20	20	27	26	25	25	28	28	28	28	27	28	28	28	28	28	27	26	14	11	10.8 days
Cash Conversion Cycle	162	159	155	151	148	145	173	173	173	174	209	213	215	213	212	209	204	200	223	178	177.8 days
Fixed Asset Turnover	snapshot only																				5.873
Operating Cycle	snapshot only																				188.5 days
Cash Velocity	snapshot only																				6.414
Capital Intensity	snapshot only																				1.348

Growth (YoY)

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue	17.2%	19.2%	17.8%	14.3%	8.6%	7.8%	6.7%	3.4%	3.2%	1.5%	-0.5%	-1.9%	-3.9%	-3.0%	0.1%	2.6%	5.9%	6.9%	7.0%	26.4%	26.39%
Net Income	28.2%	37.9%	32.8%	14.3%	6.3%	0.3%	2.2%	-2.2%	-3.9%	-6.3%	-9.3%	-12.4%	-11.7%	-4.7%	-0.7%	8.9%	11.0%	4.2%	0.8%	-31.6%	-31.62%
EPS	28.2%	38.8%	35.2%	17.5%	9.2%	3.3%	5.2%	0.5%	-1.5%	-5.0%	-8.7%	-12.6%	-12.3%	-5.1%	-1.2%	8.4%	10.6%	4.0%	0.6%	-50.3%	-50.29%
FCF	29.7%	16.8%	-6.3%	-18.8%	-24.6%	-24.5%	-24.7%	-23.4%	-20.1%	-17.5%	1.4%	18.7%	45.0%	58.9%	40.1%	20.5%	10.4%	-2.9%	-12.9%	-57.4%	-57.37%
EBITDA	26.0%	32.4%	25.1%	10.8%	4.0%	0.5%	3.5%	0.0%	1.0%	1.2%	-1.6%	-1.8%	-2.5%	0.3%	3.5%	7.6%	8.2%	3.6%	-1.1%	-12.3%	-12.29%
Op. Income	24.8%	33.2%	27.3%	13.0%	7.5%	3.2%	6.3%	0.7%	0.4%	-1.1%	-6.4%	-8.8%	-10.1%	-4.9%	1.1%	8.6%	10.0%	3.3%	2.0%	-23.7%	-23.73%
OCF Growth	snapshot only																				-48.60%
Asset Growth	snapshot only																				11.64%
Equity Growth	snapshot only																				40.07%
Debt Growth	snapshot only																				-17.32%
Shares Change	snapshot only																				37.56%

Growth (CAGR)

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue 3Y	3.9%	4.6%	4.8%	6.1%	6.4%	7.0%	7.3%	8.0%	9.5%	9.3%	7.7%	5.0%	2.5%	2.0%	2.0%	1.3%	1.6%	1.7%	2.1%	8.3%	8.33%
Revenue 5Y	4.9%	5.2%	5.1%	5.5%	5.6%	5.6%	5.2%	4.8%	4.7%	4.6%	4.1%	3.9%	3.6%	3.8%	4.2%	4.8%	6.0%	6.2%	6.0%	8.5%	8.49%
EPS 3Y	1.5%	1.5%	12.7%	12.3%	11.6%	10.3%	8.8%	10.7%	11.3%	10.9%	9.1%	1.1%	-1.9%	-2.3%	-1.8%	-1.6%	-1.5%	-2.1%	-3.2%	-22.2%	-22.20%
EPS 5Y	12.1%	12.9%	11.9%	11.9%	11.8%	11.3%	1.2%	1.0%	77.7%	72.6%	6.6%	4.5%	3.7%	3.9%	3.0%	5.1%	6.0%	6.1%	5.2%	-11.1%	-11.08%
Net Income 3Y	1.4%	1.3%	5.3%	6.0%	6.6%	6.5%	6.1%	8.7%	9.4%	9.0%	7.2%	-0.7%	-3.4%	-3.6%	-2.7%	-2.3%	-2.0%	-2.4%	-3.2%	-13.3%	-13.28%
Net Income 5Y	6.2%	6.9%	5.8%	5.7%	5.5%	4.9%	1.0%	91.6%	67.9%	63.8%	1.6%	0.4%	0.6%	1.5%	1.5%	4.1%	5.1%	5.2%	4.3%	-6.1%	-6.12%
EBITDA 3Y	3.5%	4.2%	5.4%	7.2%	7.1%	7.3%	6.9%	8.6%	9.8%	10.4%	8.4%	2.8%	0.8%	0.7%	1.8%	1.9%	2.1%	1.7%	0.3%	-2.5%	-2.50%
EBITDA 5Y	6.7%	6.8%	5.8%	5.8%	5.5%	5.1%	4.8%	3.5%	3.1%	2.9%	3.6%	3.9%	3.9%	4.6%	4.5%	6.2%	6.9%	6.9%	5.5%	0.5%	0.53%
Gross Profit 3Y	3.3%	4.4%	4.5%	6.0%	6.2%	6.5%	7.3%	8.2%	10.0%	10.6%	9.0%	6.0%	3.4%	2.5%	2.6%	1.7%	2.2%	2.5%	2.6%	6.5%	6.46%
Gross Profit 5Y	4.7%	5.2%	5.0%	5.4%	5.3%	5.1%	4.8%	4.4%	4.5%	4.6%	4.3%	4.2%	4.1%	4.3%	4.7%	5.4%	6.5%	6.9%	6.5%	7.3%	7.30%
Op. Income 3Y	3.5%	4.3%	3.6%	5.7%	5.9%	5.8%	7.2%	9.1%	10.4%	10.7%	8.2%	1.3%	-1.0%	-1.0%	0.2%	-0.1%	-0.2%	-1.0%	-1.2%	-8.9%	-8.92%
Op. Income 5Y	6.3%	6.6%	5.6%	6.1%	6.1%	5.8%	5.7%	4.4%	3.6%	3.0%	2.0%	1.6%	1.4%	2.2%	3.1%	5.2%	5.9%	5.9%	5.5%	-3.0%	-2.97%
FCF 3Y	6.2%	8.6%	6.7%	6.6%	0.7%	-1.2%	-3.1%	0.3%	-7.9%	-10.0%	-10.6%	-9.6%	-4.4%	-0.3%	2.3%	3.1%	8.5%	8.4%	7.4%	-15.2%	-15.21%
FCF 5Y	5.0%	4.3%	1.6%	0.4%	-3.5%	-4.5%	-6.4%	-6.6%	-6.3%	-4.4%	-1.5%	1.9%	3.4%	4.8%	5.3%	7.6%	4.6%	2.4%	-2.7%	-17.6%	-17.64%
OCF 3Y	8.8%	9.0%	7.3%	6.3%	0.5%	-0.1%	-1.7%	-0.5%	-6.1%	-7.2%	-8.6%	-7.9%	-4.2%	-1.9%	0.7%	1.4%	5.2%	4.9%	2.2%	-13.9%	-13.88%
OCF 5Y	5.6%	5.5%	3.5%	2.5%	-0.7%	-1.4%	-2.6%	-2.7%	-1.7%	-1.5%	-0.1%	2.1%	2.3%	3.5%	3.5%	4.2%	1.5%	0.4%	-3.8%	-14.6%	-14.57%
Assets 3Y	-19.0%	-19.0%	-6.0%	-6.0%	-6.0%	-6.0%	8.7%	8.7%	8.7%	8.7%	17.7%	17.7%	17.7%	17.7%	13.7%	13.7%	13.7%	13.7%	15.7%	15.7%	15.71%
Assets 5Y	-7.8%	-7.8%	-7.9%	-7.9%	-7.9%	-7.9%	-9.3%	-9.3%	-9.3%	-9.3%	4.4%	4.4%	4.4%	4.4%	12.2%	12.2%	12.2%	12.2%	12.4%	12.4%	12.35%
Equity 3Y	-53.0%	-53.0%	-38.3%	-38.3%	-38.3%	-38.3%	—	—	—	—	70.5%	70.5%	70.5%	70.5%	70.7%	70.7%	70.7%	70.7%	71.9%	71.9%	71.87%
Book Value 3Y	-49.2%	-49.4%	-34.0%	-34.7%	-35.4%	-36.1%	—	—	—	—	73.5%	73.5%	73.0%	72.7%	72.4%	71.9%	71.5%	71.1%	71.8%	54.2%	54.20%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue Stability	0.67	0.66	0.70	0.80	0.76	0.74	0.76	0.82	0.77	0.76	0.77	0.83	0.81	0.80	0.82	0.76	0.74	0.75	0.82	0.75	0.752
Earnings Stability	0.11	0.11	0.28	0.33	0.35	0.34	0.59	0.62	0.63	0.60	0.34	0.27	0.21	0.24	0.22	0.22	0.16	0.12	0.09	0.38	0.378
Margin Stability	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.98	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.98	0.98	0.97	0.968
Rev. Growth Consistency	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.000
Earn. Growth Consistency	0.50	0.50	0.50	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	0.00	0.000
FCF Positive Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Earnings Persistence	0.89	0.85	0.87	0.94	0.97	1.00	0.99	0.99	0.98	0.97	0.96	0.95	0.95	0.98	1.00	0.96	0.96	0.98	1.00	0.87	0.874
Earnings Smoothness	0.75	0.68	0.72	0.87	0.94	1.00	0.98	0.98	0.96	0.94	0.90	0.87	0.88	0.95	0.99	0.92	0.90	0.96	0.99	0.62	0.624
ROE Trend	—	—	—	—	—	—	-0.66	-0.92	-1.04	-1.15	-1.09	-1.12	-1.11	-1.05	-0.63	-0.59	-0.57	-0.56	-0.20	-0.27	-0.267
Gross Margin Trend	0.00	0.01	0.01	0.01	0.00	-0.00	0.00	-0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.00	-0.00	-0.00	-0.01	-0.04	-0.045
FCF Margin Trend	0.03	0.01	-0.02	-0.03	-0.06	-0.07	-0.09	-0.09	-0.07	-0.06	-0.03	0.01	0.05	0.07	0.06	0.05	0.04	0.02	-0.01	-0.12	-0.122
Sustainable Growth Rate	83.3%	87.6%	2.3%	2.3%	2.3%	2.3%	1.6%	1.6%	1.5%	1.5%	77.6%	72.9%	72.0%	75.3%	42.8%	44.1%	44.4%	43.6%	29.3%	20.5%	20.47%
Internal Growth Rate	32.4%	34.7%	30.5%	31.1%	31.0%	30.7%	28.5%	27.6%	26.8%	25.8%	19.4%	18.0%	17.7%	18.7%	16.1%	16.7%	16.8%	16.5%	15.4%	10.3%	10.28%

Cash Flow Quality

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
OCF/Net Income	1.21	1.15	1.08	1.03	0.91	0.91	0.86	0.89	0.85	0.87	0.94	1.11	1.18	1.21	1.19	1.15	1.13	1.12	1.02	0.87	0.868
FCF/OCF	0.80	0.79	0.77	0.78	0.76	0.75	0.71	0.71	0.68	0.68	0.73	0.77	0.80	0.82	0.81	0.82	0.83	0.83	0.83	0.68	0.677
FCF/Net Income	snapshot only																				0.588
OCF/EBITDA	snapshot only																				0.422
CapEx/Revenue	6.0%	6.2%	6.0%	5.6%	5.4%	5.4%	5.9%	6.0%	6.2%	6.1%	5.4%	5.3%	5.0%	4.5%	4.8%	4.7%	4.1%	4.1%	3.6%	3.3%	3.34%
CapEx/Depreciation	snapshot only																				0.408
Accruals Ratio	-0.05	-0.04	-0.02	-0.01	0.02	0.02	0.03	0.02	0.03	0.03	0.01	-0.02	-0.03	-0.03	-0.03	-0.02	-0.02	-0.02	-0.00	0.01	0.012
Sloan Accruals	snapshot only																				0.166
Cash Flow Adequacy	snapshot only																				3.095
Earnings Quality Score	snapshot only																				0.750

Dividends & Buybacks

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
FCF Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	51.7%	70.9%	93.7%	91.7%	89.6%	90.9%	88.5%	76.3%	55.4%	33.6%	10.9%	2.3%	2.3%	2.1%	2.1%	2.2%	2.2%	2.2%	2.3%	2.8%	2.83%
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	1.5%	2.2%	2.8%	3.4%	3.1%	3.9%	3.1%	2.9%	2.4%	1.3%	0.4%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.05%
Net Buyback Yield	1.5%	2.2%	2.8%	3.4%	3.1%	3.9%	3.1%	2.9%	2.4%	1.3%	0.4%	0.1%	0.1%	0.1%	0.1%	0.1%	0.0%	0.0%	0.0%	-0.0%	-0.01%
Total Shareholder Return	1.5%	2.2%	2.8%	3.4%	3.1%	3.9%	3.1%	2.9%	2.4%	1.3%	0.4%	0.1%	0.1%	0.1%	0.1%	0.1%	0.0%	0.0%	0.0%	-0.0%	-0.01%

DuPont Factors

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Tax Burden (NI/EBT)	0.85	0.86	0.86	0.86	0.86	0.86	0.84	0.84	0.84	0.84	0.87	0.88	0.88	0.87	0.84	0.84	0.84	0.85	0.85	0.86	0.857
Interest Burden (EBT/EBIT)	0.95	0.95	0.95	0.95	0.95	0.95	0.94	0.94	0.93	0.90	0.88	0.86	0.86	0.88	0.89	0.91	0.92	0.91	0.92	0.85	0.851
EBIT Margin	0.31	0.31	0.31	0.30	0.30	0.29	0.30	0.29	0.29	0.29	0.28	0.27	0.27	0.28	0.29	0.29	0.28	0.27	0.26	0.16	0.163
Asset Turnover	0.99	1.01	0.94	0.97	0.98	0.99	0.93	0.93	0.94	0.94	0.75	0.74	0.73	0.73	0.64	0.65	0.66	0.68	0.66	0.78	0.782
Equity Multiplier	340.22	340.22	9.90	9.90	9.90	9.90	7.31	7.31	7.31	7.31	4.78	4.78	4.78	4.78	3.08	3.08	3.08	3.08	2.20	2.20	2.196

Per Share

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
EPS (Diluted TTM)	$10.63	$11.23	$11.28	$11.56	$11.60	$11.60	$11.87	$11.61	$11.43	$11.02	$10.83	$10.15	$10.02	$10.46	$10.69	$11.00	$11.09	$10.88	$10.75	$5.47	$5.47
Book Value/Share	$3.73	$3.75	$5.98	$6.03	$6.07	$6.12	$8.46	$8.50	$8.55	$8.51	$19.40	$19.36	$19.35	$19.33	$30.66	$30.62	$30.65	$30.67	$42.86	$31.18	$186.17
Tangible Book/Share	$-7.58	$-7.61	$-5.09	$-5.13	$-5.17	$-5.20	$-2.57	$-2.58	$-2.60	$-2.59	$-13.22	$-13.20	$-13.19	$-13.18	$-0.59	$-0.59	$-0.59	$-0.59	$11.09	$8.07	$8.07
Revenue/Share	$42.97	$44.21	$45.36	$47.05	$47.94	$49.10	$49.83	$50.00	$50.71	$50.55	$49.85	$48.94	$48.38	$48.82	$49.60	$49.96	$51.06	$52.09	$52.96	$45.90	$45.90
FCF/Share	$10.33	$10.12	$9.43	$9.28	$8.01	$7.87	$7.31	$7.30	$6.56	$6.58	$7.46	$8.65	$9.44	$10.42	$10.39	$10.37	$10.38	$10.10	$9.03	$3.21	$3.21
OCF/Share	$12.89	$12.88	$12.17	$11.92	$10.59	$10.50	$10.26	$10.29	$9.69	$9.64	$10.16	$11.26	$11.86	$12.64	$12.78	$12.71	$12.50	$12.21	$10.92	$4.75	$4.75
Cash/Share	$7.13	$7.16	$9.27	$9.34	$9.41	$9.48	$8.07	$8.12	$8.16	$8.12	$6.68	$6.66	$6.66	$6.65	$5.45	$5.45	$5.45	$5.46	$9.84	$7.16	$5.62
EBITDA/Share	$15.34	$15.97	$16.00	$16.36	$16.40	$16.53	$17.05	$16.82	$16.98	$16.97	$16.88	$16.48	$16.43	$16.94	$17.38	$17.65	$17.72	$17.51	$17.15	$11.25	$11.25
Debt/Share	$23.37	$23.47	$26.07	$26.27	$26.47	$26.65	$27.89	$28.04	$28.19	$28.07	$41.18	$41.09	$41.08	$41.04	$28.54	$28.51	$28.54	$28.55	$23.55	$17.13	$17.13
Net Debt/Share	$16.24	$16.31	$16.80	$16.93	$17.06	$17.18	$19.82	$19.93	$20.03	$19.95	$34.50	$34.43	$34.42	$34.39	$23.09	$23.06	$23.08	$23.10	$13.71	$9.98	$9.98

Academic Models

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	7.554
Altman Z-Prime	snapshot only																				13.781
Piotroski F-Score	7	8	8	9	7	6	6	5	6	5	5	5	4	5	5	5	5	5	5	4	4
Beneish M-Score	-2.62	-2.64	-2.52	-2.46	-2.32	-2.31	-2.19	-2.23	-2.21	-2.24	-2.08	-2.16	-2.19	-2.20	-2.54	-2.53	-2.52	-2.55	-2.34	-1.85	-1.850
Ohlson O-Score	snapshot only																				-8.378
ROIC (Greenblatt)	snapshot only																				23.40%
Net-Net WC	snapshot only																				$-6.50
EVA	snapshot only																				$213971851.67

Credit

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Credit Rating	snapshot only																				AA-
Credit Score	84.30	83.94	86.68	87.24	87.61	87.13	87.13	86.51	85.37	85.37	81.27	80.87	81.38	79.66	84.71	87.12	87.32	87.32	86.12	82.30	82.303
Credit Grade	snapshot only																				4
Credit Trend	snapshot only																				-4.817
Implied Spread (bps)	snapshot only																				100.000
Industry Credit Rank	snapshot only																				100
Sector Credit Rank	snapshot only																				83

WAT NYSE

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet